Role of the tumor board when prescribing mutant isocitrate dehydrogenase inhibitors to patients with isocitrate dehydrogenase-mutant glioma. [PDF]
Roth P +4 more
europepmc +1 more source
Leptomeningeal Enhancement Manifesting as a Treatment-Related Change in Isocitrate Dehydrogenase-Wildtype Glioblastoma Mimicking Leptomeningeal Metastases on Contrast-Enhanced FLAIR MRI: A Case Report. [PDF]
Kang JH +5 more
europepmc +1 more source
Habitat subregions analysis based on neurite orientation dispersion and density imaging enhances isocitrate dehydrogenase genotyping in glioma. [PDF]
Yang Z +7 more
europepmc +1 more source
Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis. [PDF]
Jungk C +8 more
europepmc +1 more source
Severe Chemoradiotherapy Toxicity in a Pediatric Patient with Leigh Syndrome and Grade IV Isocitrate Dehydrogenase-Mutant Astrocytoma: A Case Report. [PDF]
Granberry MT +5 more
europepmc +1 more source
Correction to "Isocitrate Dehydrogenase 2 Mutation Promotes Cytarabine Resistance in Acute Myeloid Leukemia by Warburg Effect". [PDF]
europepmc +1 more source
Differential isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 mutation-related landscape in intrahepatic cholangiocarcinoma. [PDF]
Xu S +9 more
europepmc +1 more source
Transcriptomic Profile of Isocitrate Dehydrogenase Mutant Type of Lower-Grade Glioma Reveals Molecular Changes for Prognosis. [PDF]
Cho SB.
europepmc +1 more source
Studies on the Mechanism of Action of Isocitric Dehydrogenase
openaire +2 more sources
Improvement of magnetic resonance imaging diffusion metric 'slow diffusion coefficient (SDC)' over apparent diffusion coefficient (ADC) for isocitrate dehydrogenase (IDH) genotyping in diffuse gliomas. [PDF]
Zheng WY +6 more
europepmc +1 more source

